Position in LH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$23,576,280
+$876,353 QoQ
Shares Held
84,201
-1.0% QoQ
Ownership
0.104%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#105
of 1,044 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 83%
Shared 0%
None 17%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Cerity Partners LLC holds $443,202,768 across 29 Diagnostics & Research names. LH ranks #7 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
591,658 | $112,699,014 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
199,575 | $100,058,919 | |
| 3 | NTRA |
Natera, Inc.
|
104,096 | $28,256,858 | |
| 4 | MEDP |
Medpace Holdings, Inc.
|
52,906 | $28,018,487 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
141,227 | $27,287,880 | |
| 6 | ILMN |
Illumina, Inc.
|
154,690 | $27,199,141 | |
| 7 | LH |
Labcorp Holdings Inc.
This page
|
84,201 | $23,576,280 | |
| 8 | A |
Agilent Technologies, Inc.
|
163,679 | $21,741,480 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,576,280 | 84,201 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $22,699,927 | 85,079 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $17,372,937 | 69,248 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $22,500,911 | 78,384 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $21,648,937 | 82,469 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $19,740,308 | 84,817 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $19,527,973 | 85,156 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $18,256,975 | 81,694 | Shares | Other | 2024-11-12 | |
| 2024-06-30 | $14,832,622 | 72,884 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||